Suppr超能文献

医疗保健专业人员和公众对基于个性化风险的癌症筛查的可接受性和认知:一项系统评价和荟萃分析。

Acceptability and perceptions of personalised risk-based cancer screening among health-care professionals and the general public: a systematic review and meta-analysis.

作者信息

Tan Naomi Q P, Nargund Renu S, Douglas Elisa E, Lopez-Olivo Maria A, Resong Paul J, Ishizawa Sayaka, Nofal Sara, Krause Kate, Volk Robert J, Toumazis Iakovos

机构信息

Division of Oncology, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ, USA; Rutgers Cancer Institute, New Brunswick, NJ, USA; Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

出版信息

Lancet Public Health. 2025 Feb;10(2):e85-e96. doi: 10.1016/S2468-2667(24)00278-0.

Abstract

BACKGROUND

Personalised risk-based screening (PRBS) can enhance the efficiency of cancer screening programnes, but little is known about support for its implementation among the general public and health-care professionals. We aimed to summarise the acceptability and perceptions of PRBS for breast, cervical, colorectal, lung, and prostate cancer screening among these groups.

METHODS

We conducted a systematic review and meta-analysis of original research studies reporting on breast, cervical, colorectal, lung, and prostate cancer screening; personalised risk assessments to guide PRBS; and the acceptability of and receptibility towards these approaches among the general public, health-care professionals, or both. We searched MEDLINE, Embase, Cochrane Central, PsycINFO, and CINAHL Plus for articles published between Jan 1, 2010, and April 30, 2024. Studies not reporting on the outcomes of interest and with insufficient data for analysis were excluded. Six reviewers independently screened articles, and risk of bias was assessed using the Mixed Methods Appraisal Tool. Qualitative data were analysed thematically. Quantitative data were analysed with use of random-effects meta-analysis for outcomes that had at least two studies. The study protocol was registered at PROSPERO, CRD42022354287.

FINDINGS

Our search identified 4491 unique records. After screening, 63 studies were included in our analysis, of which 36 (57%) included the general public, 21 (33%) included health-care professionals, and six (11%) included both. The majority of studies focused on breast cancer screening (43 [68%] studies), and were from North America (28 [44%]) and Europe (28 [44%]). Qualitative findings were analysed thematically, and the extracted quantitative findings were synthesised under the following topics: acceptability and perceptions of personalised risk assessments among the general public; acceptability and perceptions of PRBS among the general public; acceptability and perceptions of PRBS among health-care professionals; and barriers and facilitators to PRBS implementation among health-care professionals. The general public and health-care professionals generally found PRBS acceptable, but they needed more information about how risk was calculated and the accuracy of risk scores. Additionally, both groups were cautious about reducing screening frequencies for individuals at low risk and cited barriers such as the time and resources needed to implement an effective PRBS programme. The pooled estimate for acceptability of PRBS was 78% (95% CI 66-88) among the general public and 86% (64-99) among health-care professionals.

INTERPRETATION

The general public and health-care professionals both viewed personalised risk assessments as providing valuable information and PRBS as a logical next step to increase the quality of patient care and improve cancer mortality. However, implementation barriers at the public, health-care professional, and system level need to be addressed.

FUNDING

National Cancer Institute and Cancer Prevention and Research Institute of Texas.

摘要

背景

基于风险的个性化筛查(PRBS)可提高癌症筛查项目的效率,但对于公众和医疗保健专业人员对其实施的支持情况知之甚少。我们旨在总结这些群体对乳腺癌、宫颈癌、结直肠癌、肺癌和前列腺癌筛查的PRBS的可接受性和看法。

方法

我们对报告乳腺癌、宫颈癌、结直肠癌、肺癌和前列腺癌筛查、用于指导PRBS的个性化风险评估以及公众、医疗保健专业人员或两者对这些方法的可接受性和接受程度的原始研究进行了系统评价和荟萃分析。我们在MEDLINE、Embase、Cochrane Central、PsycINFO和CINAHL Plus中检索了2010年1月1日至2024年4月30日期间发表的文章。未报告感兴趣结果且数据不足无法分析的研究被排除。六名评审员独立筛选文章,并使用混合方法评估工具评估偏倚风险。定性数据进行了主题分析。对于至少有两项研究的结果,定量数据采用随机效应荟萃分析进行分析。研究方案已在PROSPERO注册,注册号为CRD42022354287。

结果

我们的检索确定了4491条独特记录。筛选后,63项研究纳入我们的分析,其中36项(57%)纳入了公众,21项(33%)纳入了医疗保健专业人员,6项(11%)两者都有纳入。大多数研究聚焦于乳腺癌筛查(43项[68%]研究),且来自北美(28项[44%])和欧洲(28项[44%])。定性结果进行了主题分析,提取的定量结果在以下主题下进行了综合:公众对个性化风险评估的可接受性和看法;公众对PRBS的可接受性和看法;医疗保健专业人员对PRBS的可接受性和看法;以及医疗保健专业人员实施PRBS的障碍和促进因素。公众和医疗保健专业人员总体上认为PRBS是可接受的,但他们需要更多关于风险如何计算以及风险评分准确性的信息。此外,两组对于降低低风险个体的筛查频率都持谨慎态度,并列举了实施有效的PRBS项目所需的时间和资源等障碍。PRBS在公众中的汇总可接受性估计为78%(95%CI 66 - 88),在医疗保健专业人员中为86%(64 - 99)。

解读

公众和医疗保健专业人员都认为个性化风险评估提供了有价值的信息,且PRBS是提高患者护理质量和改善癌症死亡率的合理下一步举措。然而,需要解决公众、医疗保健专业人员和系统层面的实施障碍。

资助

美国国家癌症研究所和德克萨斯州癌症预防与研究所。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9fc/11817692/a9e4b6fd1732/nihms-2054260-f0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验